Try a new search

Format these results:

Searched for:

in-biosketch:true

person:griesa02

Total Results:

142


Association of Functional, Academic, Motor, and Cognitive Deficits in Graft Failure in Pediatric Liver Transplantation

Donnelly, Conor; Patel, Suhani S; Jaffe, Ian S; Akizhanov, Daniyar; Chiang, Teresa Po-Yu; Long, Jane J; Liyanage, Luckmini; Griesemer, Adam; Segev, Dorry L; Massie, Allan B
INTRODUCTION/BACKGROUND:Predicting graft failure risk in pediatric liver transplantation (LT) recipients could identify areas for improving management. Persistent cognitive, motor, academic, and functional deficits are common in recipients and their impact on graft survival following LT helps inform risk prediction. METHODS:Using SRTR data 2008-2023, we evaluated the cognitive, motor, academic, and functional deficits of LT recipients at time of transplant to 14 years post-LT. We compared all cause graft failure (ACGF) among patients with versus without pre-LT and 1-year post-LT deficits using Cox regression, adjusting for recipient characteristics. We calculated an individual risk score for ACGF. RESULTS:In 8062 pediatric LT recipients median age 3 (IQR: 1, 10), 28.0%, 29.5%, 35.0%, and 79.8% of recipients had pre-LT deficits in cognition, motor, academic activity, and functional status respectively. This decreased to 23.0%, 18.1%, 14.2%, and 38.7% 1-year post-LT. Increased hazard of ACGF was noted in recipients with pre-LT decreased functional status (aHR = 1.13 (per 10% decrease), 95% CI: 1.10-1.15, p < 0.001), definite motor delay (aHR = 1.60, 95% CI: 1.21-2.10, p < 0.001), and inability to participate in academics (aHR = 1.49, 95% CI: 1.08-1.89, p = 0.01), but not delays in cognition (aHR = 0.91, 95% CI: 0.69-1.21, p = 0.19). Our risk score predicting ACGF demonstrated improved predictive performance compared to clinical parameters alone (C-statistic = 0.70 (0.67, 0.72) vs. 0.66 (0.64, 0.69), p < 0.001). CONCLUSIONS:Pediatric LT recipients with pre- or post-LT motor, academic, and functional deficits are at higher risk for ACGF. Care should be taken to assess deficits to identify patients who may benefit from functional intervention to potentially reduce ACGF risk.
PMID: 40152814
ISSN: 1399-0012
CID: 5817472

Unused Samples from Clinical Blood Draws as a Resource for Maximizing Research Samples while Mitigating Iatrogenic Anemia Risks: A Pilot Study

Jaffe, Ian S; Aljabban, Imad; Kim, Jacqueline I; Dundas, Nicolas; Khalil, Karen; Rosa, Stefany; Zayas, Zasha; Nally, McKenna; Gallego, Estefania; Griesemer, Adam; Montgomery, Robert A; Stern, Jeffrey M
BACKGROUND/UNASSIGNED:Translational research driven by large-scale biological testing requires significant volumes of blood for research testing. However, blood is also required for clinical management of research subjects, which must take priority. Paradoxically, much of the blood drawn for clinical management goes unused. Here, we present our approach for retrieving unused blood samples collected for clinical management and recycling them for research purposes. METHODS/UNASSIGNED:Clinical Blood samples were collected for 60 days during a 61-day xenotransplantation experiment in a brain-dead decedent. Twice weekly, research staff went to the chemistry and hematology laboratories and collected stored blood, serum, and plasma samples that were >12 hours old. Sample collection and storage before retrieval was per standard clinical protocols. Samples were de-identified and relabeled and brought to a central biorepository for processing and storage. The quantity of plasma, serum, red blood cells (RBCs), and peripheral blood mononuclear cells (PBMCs) collected from clinical labs and bespoke research blood draws were compared. RESULTS/UNASSIGNED:Unused blood from clinical samples yielded a minimum of 6.0 ml per day of plasma, representing 62% of all plasma obtained. Serum was only recoverable on 13 days (22%), with a mean 2.3 ml collected on those days, representing 8% of all serum obtained. PBMCs were only recoverable on six days (10%). CONCLUSIONS/UNASSIGNED:Overdrawn clinical laboratory samples represent an untapped resource of blood samples for research and can help augment samples collected explicitly for research purposes. With careful planning, this represents an opportunity to minimize iatrogenic blood loss in clinical-translational research.
PMCID:12047949
PMID: 40321263
CID: 6076247

Donor-reactive T cells and innate immune cells promote pig-to-human decedent xenograft rejection

Fathi, Farshid; Suek, Nathan; Vermette, Benjamin; Breen, Kevin; Saad, Yasmeen S; Bay, Constanza; Parks, Christopher A; Stern, Jeffrey; Khalil, Karen; Kim, Jacqueline; Jaffe, Ian S; Aljabban, Imad; Novikova, Ekaterina; Severa, Elizabeth; Herati, Ramin Sedaghat; Burdorf, Lars; Griesemer, Adam D; Montgomery, Robert A; Sykes, Megan
Xenotransplantation of pig organs is a promising solution to the organ shortage; however, rejection remains a major obstacle. Pig-to-human decedent transplantation provides an opportunity to study immune barriers to xenotransplantation experimentally. We tracked donor-reactive T cell dynamics in a 61-day pig-to-human decedent thymokidney xenotransplant. Xenogeneic donor-reactive T cell clones (XDRTCCs) identified using high-throughput TCRB CDR3 sequencing expanded markedly in peripheral blood in association with apparent antibody-mediated rejection (AMR). Single-cell RNA and TCR sequencing of leukocytes from the xenograft showed XDRTCC infiltration and effector transcript expression during AMR. Additionally, γδ and NK cells with cytotoxic effector phenotypes were prominent in the rejecting xenograft. These data suggest that improved suppression of innate immunity and T cell responses might enhance the success of xenotransplantation.
PMCID:12045455
PMID: 40313748
ISSN: 2693-5015
CID: 6076246

Prdm16-dependent antigen-presenting cells induce tolerance to intestinal antigens

Fu, Liuhui; Upadhyay, Rabi; Pokrovskii, Maria; Chen, Francis M; Romero-Meza, Gabriela; Griesemer, Adam; Littman, Dan R
The gastrointestinal tract is continuously exposed to foreign antigens in food and commensal microbes with potential to induce adaptive immune responses. Peripherally induced T regulatory (pTreg) cells are essential for mitigating inflammatory responses to these agents1-4. While RORγt+ antigen-presenting cells (RORγt-APCs) were shown to program gut microbiota-specific pTreg5-7, their definition remains incomplete, and the APC responsible for food tolerance has remained elusive. Here, we identify a distinct subset of RORγt-APCs, designated tolerogenic dendritic cells (tDC), required for differentiation of both food- and microbiota-specific pTreg cells and for establishment of oral tolerance. tDC development and function require expression of the transcription factors Prdm16 and RORγt, as well as a unique Rorc(t) cis-regulatory element. Gene expression, chromatin accessibility, and surface marker analysis establish tDC as myeloid in origin, distinct from ILC3, and sharing epigenetic profiles with classical DC. Upon genetic perturbation of tDC, we observe a substantial increase in food antigen-specific T helper 2 (Th2) cells in lieu of pTreg, leading to compromised tolerance in mouse models of asthma and food allergy. Single-cell analyses of freshly resected mesenteric lymph nodes from a human organ donor, as well as multiple specimens of human intestine and tonsil, reveal candidate tDC with co-expression of PRDM16 and RORC and an extensive transcriptome shared with mice, highlighting an evolutionarily conserved role across species. Our findings suggest that a better understanding of how tDC develop and how they regulate T cell responses to food and microbial antigens could offer new insights into developing therapeutic strategies for autoimmune and allergic diseases as well as organ transplant tolerance.
PMID: 39091750
ISSN: 2692-8205
CID: 6076245

Coordinated circulating and tissue-based T cell responses precede xenograft rejection

Novikova, Ekaterina; Severa, Elizabeth; Chen, Han; Doepke, Elizabeth; Chacon, Fiorella; Fathi, Farshid; Suek, Nathan; Vermette, Benjamin; Bombardi, Robin; Schmauch, Eloi; Williams, Simon H; Kim, Jacqueline I; Aljabban, Imad; Eitan, Tal; Jaffe, Ian S; Hammond, Grace; Khalil, Karen; Mattoo, Aprajita; Tatapudi, Vasishta; Skolnik, Edward; Weldon, Elaina P; Ayares, David; Nellore, Anoma; Sykes, Megan; Griesemer, Adam D; Stern, Jeffrey M; Keating, Brendan J; Montgomery, Robert A; Herati, Ramin Sedaghat
Despite the life-saving successes of solid organ transplantation, the number of individuals needing organ transplant far exceeds the number of organs available for use each year. Porcine xenotransplantation, or the use of pig organs for transplantation in people, holds substantial promise but xenograft rejection in humans is poorly understood. T cell rejection by the host immune system is a major challenge for human allografts and may limit the longevity of porcine xenografts. To study the xenograft rejection, we evaluated T cell responses and repertoire dynamics across tissues following porcine thymokidney transplantation in a decedent model over 61 days after bilateral native kidney nephrectomy. Despite induction with anti-thymocyte globulin and ongoing immune suppression consisting of rituximab, corticosteroids, calcineurin inhibition, and mycophenolate mofetil, human T cell infiltration of the xenograft was observed and was associated with xenograft dysfunction. Longitudinal analysis of T cell clonotypes in biopsies of thymokidney revealed accumulation of clonal human CD4 and CD8 T cell responses. Moreover, circulating activated T cells, including circulating T follicular helper (cTfh), were xeno-reactive and increased in frequency around rejection events. We confirmed clonal dominance of a single CD8 clonotype - identified as donor-reactive in a mixed lymphocyte reaction - in the circulation leading up to the acute cellular rejection event. Following re-treatment with anti-thymocyte globulin and intensification of corticosteroids, the T cell clonotypes were dramatically diminished in frequency in thymokidney and lymph nodes, though not eliminated. Over time of observation, the T cell clonotypes were shared across multiple compartments, including xenograft, circulation and lymph nodes and formed clonal families with known xeno-reactive clonotypes, suggesting a coordinated immune response against a limited pool of antigenic targets. Together, these data demonstrate T cell repertoire dynamics across tissues in the setting of xenograft rejection and highlight opportunities for early surveillance, prediction and potential intervention.
PMCID:12637509
PMID: 41279278
ISSN: 2692-8205
CID: 6076250

Characterizing the Immune Response in Pig-to-human Heart Xenografts Using a Multimodal Diagnostic System

Giarraputo, Alessia; Morgand, Erwan; Stern, Jeffrey; Mezine, Fariza; Coutance, Guillaume; Goutaudier, Valentin; Sannier, Aurelie; Certain, Anais; Hauet, Thierry; Giraud, Sebastien; Kerforne, Thomas; Allain, Geraldine; Ayares, David; Khalil, Karen; Kim, Jaqueline; Mehta, Sapna; Narula, Navneet; Reyentovich, Alex; Smith, Deane; Tissier, Renaud; Saraon, Tajinderpal; Kadosh, Bernard; DiVita, Michael; Goldberg, Randal; Pass, Harvey; Mangiola, Massimo; Bruneval, Patrick; Griesemer, Adam; Moazami, Nader; Montgomery, Robert A; Loupy, Alexandre
BACKGROUND:Porcine genome editing has revolutionized xenotransplantation, recently enabling the first pig-to-human heart xenotransplants. However, the xeno-immune response in heart xenografts remains largely unexplored. This study aimed to precisely characterize the xeno-immune response and injury in two heart xenografts, transplanted from 10-gene-edited pigs into brain-dead human recipients. METHODS:We analyzed xenograft biopsies at 66-hour post-reperfusion using a multimodal phenotyping approach combining: morphological evaluation, immunophenotyping, ultrastructural assessment, automated quantification of multiplex immunofluorescence staining and gene expression profiling. Xenografts before implantation and wild-type pig hearts with and without ischemia reperfusion injury and brain death were used as controls. RESULTS:Both xenografts showed evidence of endothelial activation and mild microvascular inflammation without capillary C4d deposition. Immune infiltrates were mainly composed of CD15+ and CD68+ innate immune cells. Ultrastructural assessment showed endothelial swelling with occasional intravascular leucocytes. Deep-learning based automated multiplex immunofluorescence analysis confirmed that microvascular inflammation was primarily associated with CD15+ and CD68+ innate immune cells. Both xenografts showed increased expression of genes and pathways associated with monocyte/macrophage activation, neutrophil activation, interferon-gamma response, natural killer cell burden, endothelial activation, apoptosis and injury repair. This phenotype was absent in all control pig hearts, independently from ischemia reperfusion injury and brain death. CONCLUSIONS:Multimodal phenotyping of pig-to-human heart xenografts revealed early signs of xeno-immune response, characterized by mild innate microvascular inflammation, endothelial activation, and molecular signature characteristic of antibody-mediated rejection. Developing such precision diagnostic system could improve graft monitoring in future clinical settings.
PMID: 41036838
ISSN: 1524-4539
CID: 5960722

Progressive Hyperglycemia in Tolerant Miniature Swine Recipients of Composite Islet-kidney Grafts Is not due to Islet Loss but Rather to Increased Insulin Demand With Growth

Chauhan, Ishit; Llore, Nathaly P; Hirakata, Atsushi; Ishikawa, Yoshinori; Vallabhajosyula, Prashanth; Weiner, Joshua; Yamada, Kazuhiko; Sachs, David H; Griesemer, Adam
BACKGROUND:Intraportal pancreatic islet transplantation could potentially provide a cure for type 1 diabetes, but this procedure usually requires >1 infusion along with loss of function with time posttransplant. We have previously demonstrated in a major histocompatibility complex (MHC) inbred miniature swine large animal model that the construction of an "islet-kidney" (IK) by implantation of autologous donor islets under the kidney capsule several weeks before transplantation reduces the extent of islet loss. The long-term islet function in juvenile recipients, tolerant to allogeneic IKs, is evaluated in this study. METHODS:We transplanted IKs across minor (n = 3) and full MHC (n = 1) mismatches, using a tolerance-inducing regimen consisting of 12-d treatment with either cyclosporine A or FK506. All 4 recipients experienced an increase in their body mass over time and this weight gain coincided significantly (P < 0.01) with the development of hyperglycemia. To test the hypothesis that the hyperglycemia in these recipients might be due to increased body mass rather than islet loss, the grafts were subsequently retransplanted into MHC-matched, diabetic miniature swine, similar in weight to the original recipients, using the same tolerance-inducing regimen. RESULTS:All 4 of the secondary graft recipients regained glycemic control initially, with a similar, significant correlation between body weight and fasting blood glucose (P < 0.001) over time. CONCLUSIONS:These findings indicate that loss of function of a vascularized IK graft with time is likely due to increased insulin demand in a growing animal and not due to islet loss.
PMCID:12262162
PMID: 40658951
ISSN: 1534-6080
CID: 5896982

Cardiac Xenotransplantation: Current State and Future Directions

Phillips, Katherine G; Aljabban, Imad; Wolbrom, Daniel H; Griesemer, Adam; Leacche, Marzia; McGregor, Christopher; Moazami, Nader
The increasing demand for donor hearts presents both a critical challenge and a significant opportunity for innovation in cardiac transplantation. Advancements in immunosuppressive regimens and genetic engineering have reignited recent interest in xenotransplantation. Notably, 2 human patients have received genetically modified pig hearts under expanded-access authorization. They survived for 40 and 60 days, with xenograft failure preceding death in both cases. Concurrently, decedent studies have focused on monitoring the short-term physiological function of genetically modified cardiac xenografts in legally brain-dead recipients, representing a novel experimental paradigm for preclinical testing to help bridge the gap between nonhuman primate studies and clinical trials. These contemporary achievements build on a large body of exploratory efforts in cardiac xenotransplantation in nonhuman primates. Despite significant progress in overcoming hyperacute rejection, adaptive cellular and humoral immunological barriers remain. This review aims to critically evaluate the current advancements in xenotransplantation, to explore ongoing challenges, and to discuss the future potential of this innovative approach in addressing the growing demand for donor organs in cardiac transplantation.
PMID: 40623074
ISSN: 1524-4539
CID: 5890472

Scientific advances in the assessment, modification, and generation of transplantable organs for patients with end-stage organ diseases

Shaver, Ciara M; Reese, Peter P; Griesemer, Adam; Zuckermann, Andreas; Bacchetta, Matthew
The large deficit in donated organs required to provide transplantation to patients with end-stage organ disease is a global health crisis, exacerbated by regional differences in clinical practice and available resources. This deficit highlights the need for better tools to determine organ suitability for transplantation and to enhance the recovery of potential donor organs which are currently not transplanted due to concerns about organ quality. Novel organ assessment approaches, including epidemiological predictive models, advanced functional biometrics, and refined histological analysis, show potential to better identify donated organs suitable for transplantation. In addition, novel machine perfusion platforms have shown remarkable capacities to preserve and potentially modify injured organs, and a series of xenotransplantation experiments suggest a viable pathway to create a new organ supply. Collectively, these technologies will gradually alleviate the organ shortage and expand access to life-saving transplants.
PMID: 40614745
ISSN: 1474-547x
CID: 5888572

Prdm16-dependent antigen-presenting cells induce tolerance to gut antigens

Fu, Liuhui; Upadhyay, Rabi; Pokrovskii, Maria; Chen, Francis M; Romero-Meza, Gabriela; Griesemer, Adam; Littman, Dan R
The gastrointestinal tract is continuously exposed to foreign antigens in food and commensal microbes with potential to induce adaptive immune responses. Peripherally induced T regulatory (pTreg) cells are essential for mitigating inflammatory responses to these agents1-4. While RORγt+ antigen-presenting cells (RORγt-APCs) were shown to program gut microbiota-specific pTreg5-7, their definition remains incomplete, and the APC responsible for food tolerance has remained elusive. Here, we identify an APC subset required for differentiation of both food- and microbiota-specific pTreg cells and for establishment of oral tolerance. Development and function of these APCs require expression of the transcription factors Prdm16 and RORγt, as well as a unique Rorc(t) cis-regulatory element. Gene expression, chromatin accessibility, and surface marker analysis establish the pTreg-inducing APCs as myeloid in origin, distinct from ILC3, and sharing epigenetic profiles with classical dendritic cells (cDC), and designate them Prdm16+ RORγt+ tolerizing DC (tolDC). Upon genetic perturbation of tolDC, we observe a substantial increase in food antigen-specific T helper 2 (Th2) cells in lieu of pTreg, leading to compromised tolerance in mouse models of asthma and food allergy. Single-cell analyses of freshly resected mesenteric lymph nodes from a human organ donor, as well as multiple specimens of human intestine and tonsil, reveal candidate tolDC with co-expression of PRDM16 and RORC and an extensive transcriptome shared with mice, highlighting an evolutionarily conserved role across species. Our findings suggest that a better understanding of how tolDC develop and how they regulate T cell responses to food and microbial antigens could offer new insights into developing therapeutic strategies for autoimmune and allergic diseases as well as organ transplant tolerance.
PMID: 40228524
ISSN: 1476-4687
CID: 5827502